Wednesday, June 29, 2016 6:26:18 AM
CytoSorb in septic shock and multi organ failure after burn injury
Dr. Markus Engel Senior Consultant Medical ICU, Hospital Bogenhausen
Summary:
This case study reports on a 27-year-old patient who was admitted to emergency department in status post burn injury (25% TBSA) button_EN
Case presentation
Burn injury of face, arms, hands and lower legs on both sides after flash fire during work as craftsman. Primary care by emergency physician on site including intubation and analgosedation and subsequent transport to hospital by helicopter
On admission intubated and ventilated and with stable circulation requiring low dose catecholamine administration. Primary wound care and vacuseal dressing of both hands
On day 3 uneventful extubation with stable pulmonary and circulatory functions not requiring catecholamine administration
Here after debridement and closure of arm and leg wounds with Suprathel
In the following, however worsening of the cardiopulmonary and renal functions and after the pressure supported NIV approach had failed the indication for intubation was given. In the course of that further deterioration of circulatory instability requiring high dose administration of norepinephrine. Decreasing diuresis despite high doses of furosemide.
Chest x-ray diagnosis showed progressive pulmonary alterations in terms of ARDS. Echocardiography showed only low grade reduced left ventricular function and no real cardiac dysfunction.
Due to multiple organ failure because of the massive inflammatory reaction as well as the persisting high doses of catecholamines needed (norepinephrine up to 5mg/h) treatment with CytoSorb was started after renal failure had also required CRRT.
Treatment
One CytoSorb treatment sessions for a total period of 24 hours
CytoSorb was used in conjunction with CRRT (multiFiltrate, Fresenius Medical Care) in CVVHD mode
Anticoagulation: citrate
CytoSorb adsorber position: pre-hemofilter
Measurements
Demand for catecholamines
Lactate
IL – 6 levels
Results
Quick hemodynamic stabilization of the patient with significantly decreased needs for catecholamines initially and complete tapering of catecholamines after 48 hrs.
Effective reduction of lactate and IL-6 levels during the CytoSorb sessions
Patient Follow-Up
Proof of 3MRGN Pseudomonas as well as diagnosis of HIT
In the further course end of CRRT and extubation of (tracheotomized) patient
Finally discharge with stable overall situation and plain wound conditions
en_neen_IL5laktat_ENcyen
Conclusions
Treatment with CytoSorb resulted in a significant and quick stabilization of hemodynamics as well as an effective reduction of lactate and IL-6 plasma levels
Treatment was easy to apply and safe
http://cytosorb-therapy.com/the-therapy/case-of-the-week/
Recent CTSO News
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:20:45 PM
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients • GlobeNewswire Inc. • 01/17/2024 12:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/08/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:49:02 PM
- CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation • GlobeNewswire Inc. • 12/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:33:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:31:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 02:15:22 PM
- CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering • GlobeNewswire Inc. • 12/13/2023 02:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/11/2023 09:10:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:10:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:20:25 PM
- CytoSorbents Reports Third Quarter 2023 Financial and Operational Results • GlobeNewswire Inc. • 11/09/2023 09:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:54 PM
- CytoSorbents to Report Third Quarter 2023 Operating and Financial Results • GlobeNewswire Inc. • 10/27/2023 11:00:00 AM
- CytoSorbents to Present at the 8th Annual Dawson James Conference • GlobeNewswire Inc. • 10/05/2023 11:00:00 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM